Nifty

:

24008.00

Sensex

:

79454.47

-265.80 (-1.09%)
-880.34 (-1.10%)

Login

Nifty
Sensex

:
:

24008.00
79454.47

-265.80 (-1.09%)
-880.34 (-1.10%)

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 506879 | NSE: GUJTHEM

Watchlist

NSE BSE

299.15

06-Feb-2025

Open
High
Low
Previous Close

281.30
304.90
281.30
281.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

81919
243.63
390.00
192.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,932.80
55.69
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,924.06
0.25%
12.41

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.37
14.81
13.93

EBITDA CAGR (%)

10 Years
5 Years
3 Years

28.79
19.86
6.29

PAT CAGR (%)

10 Years
5 Years
3 Years

29.13
20.11
10.69

P:E (Median)

8 Years
5 Years
3 Years

15.75
19.45
26.69

P:BV (Average)

8 Years
5 Years
3 Years

9.06
9.22
10.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.49
19.53
26.08

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 5.43
P/E Ratio 59.92
Revenue 170
EBITDA 79
Net Income 59
ROA 30.5
P/B Ratio 17.59
ROE 33.76
FCFF -7.84
FCFF Yield -0.22

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 39.52 38.78 1.91% 34.72 39.54 -12.19% 38.83 49.59 -21.70% 42.01 27.59 52.27%
Expenses 20.65 21.11 -2.18% 19.32 22.82 -15.34% 20.28 26.08 -22.24% 21.08 13.22 59.46%
EBITDA 18.87 17.67 6.79% 15.39 16.72 -7.95% 18.55 23.51 -21.10% 20.93 14.36 45.75%
EBIDTM 47.74% 45.56% 44.33% 42.29% 47.78% 47.40% 49.82% 52.06%
Other Income 0.24 1.08 -77.78% 0.32 1.10 -70.91% 0.52 1.07 -51.40% 1.02 1.96 -47.96%
Interest 0.14 0.08 75.00% 0.08 0.05 60.00% 0.07 0.03 133.33% 0.08 0.03 166.67%
Depreciation 1.56 0.98 59.18% 1.44 0.88 63.64% 1.15 0.75 53.33% 0.93 0.77 20.78%
PBT 17.40 17.69 -1.64% 14.19 16.89 -15.99% 17.86 23.81 -24.99% 20.95 15.53 34.90%
Tax 4.43 4.68 -5.34% 3.63 4.34 -16.36% 4.62 6.09 -24.14% 5.06 3.84 31.77%
PAT 12.97 13.01 -0.31% 10.57 12.54 -15.71% 13.24 17.72 -25.28% 15.89 11.69 35.93%
PATM 32.82% 33.56% 30.44% 31.72% 34.09% 35.74% 37.81% 42.38%
EPS 1.19 1.19 0.00% 0.97 1.15 -15.65% 1.21 1.63 -25.77% 1.46 1.07 36.45%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 155.08 169.82 148.39 114.85 90.56 85.12 41.05 38.80 35.69 32.62 31.44 Net Sales Growth -0.27% 14.44% 29.20% 26.82% 6.39% 107.36% 5.80% 8.71% 9.41% 3.75% Cost Of Goods Sold 26.54 35.72 25.77 16.10 15.13 11.05 1.04 2.15 1.48 0.32 0.29 Gross Profit 128.54 134.10 122.61 98.75 75.43 74.07 40.01 36.65 34.21 32.30 31.15 GP Margin 82.89% 78.97% 82.63% 85.98% 83.29% 87.02% 97.47% 94.46% 95.85% 99.02% 99.08% Total Expenditure 81.33 91.09 74.76 56.81 50.23 53.29 33.69 32.56 29.64 26.59 25.17 Power & Fuel Cost - 26.53 26.41 21.73 16.57 22.86 20.20 19.33 17.99 17.15 16.16 % Of Sales - 15.62% 17.80% 18.92% 18.30% 26.86% 49.21% 49.82% 50.41% 52.58% 51.40% Employee Cost - 10.21 7.75 7.08 7.11 6.43 5.17 4.46 4.42 4.28 4.00 % Of Sales - 6.01% 5.22% 6.16% 7.85% 7.55% 12.59% 11.49% 12.38% 13.12% 12.72% Manufacturing Exp. - 13.64 10.62 9.00 9.35 10.97 5.67 5.01 4.43 3.58 3.25 % Of Sales - 8.03% 7.16% 7.84% 10.32% 12.89% 13.81% 12.91% 12.41% 10.97% 10.34% General & Admin Exp. - 2.76 2.53 1.43 1.16 0.93 0.95 0.95 0.76 0.77 0.73 % Of Sales - 1.63% 1.70% 1.25% 1.28% 1.09% 2.31% 2.45% 2.13% 2.36% 2.32% Selling & Distn. Exp. - 1.60 1.04 0.31 0.38 0.54 0.32 0.03 0.03 0.00 0.02 % Of Sales - 0.94% 0.70% 0.27% 0.42% 0.63% 0.78% 0.08% 0.08% 0% 0.06% Miscellaneous Exp. - 0.61 0.64 1.15 0.53 0.49 0.35 0.64 0.53 0.49 0.02 % Of Sales - 0.36% 0.43% 1.00% 0.59% 0.58% 0.85% 1.65% 1.49% 1.50% 2.29% EBITDA 73.74 78.73 73.63 58.04 40.33 31.83 7.36 6.24 6.05 6.03 6.27 EBITDA Margin 47.55% 46.36% 49.62% 50.54% 44.53% 37.39% 17.93% 16.08% 16.95% 18.49% 19.94% Other Income 2.10 4.37 6.59 4.05 3.27 1.70 2.21 0.17 0.36 0.17 0.09 Interest 0.37 0.23 0.18 0.83 0.98 0.92 0.16 0.42 0.41 0.38 0.39 Depreciation 5.08 3.54 2.58 2.23 1.73 1.36 1.22 1.15 1.12 1.20 1.38 PBT 70.40 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 4.59 Tax 17.74 20.17 19.50 15.41 10.70 7.58 1.79 0.97 0.51 0.00 0.00 Tax Rate 25.20% 25.43% 25.17% 26.11% 26.17% 24.25% 21.83% 20.04% 10.45% 0.00% 0.00% PAT 52.67 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 4.59 PAT before Minority Interest 52.67 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 4.59 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 33.96% 34.84% 39.07% 37.98% 33.33% 27.81% 15.62% 9.97% 12.27% 14.19% 14.60% PAT Growth -4.17% 2.05% 32.90% 44.53% 27.50% 269.27% 65.63% -11.64% -5.40% 0.87% EPS 4.83 5.43 5.32 4.00 2.77 2.17 0.59 0.36 0.40 0.42 0.42

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 201.38 149.15 103.32 69.95 42.20 18.52 12.11 8.21 3.84 -0.79 Share Capital 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 Total Reserves 194.11 141.88 96.06 62.68 34.93 11.26 4.85 0.95 -3.42 -8.05 Non-Current Liabilities 3.58 1.90 2.02 2.49 4.54 1.43 0.46 1.32 1.52 5.69 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 1.05 1.78 Unsecured Loans 0.00 0.00 0.00 0.00 3.18 0.00 0.00 0.40 0.00 3.50 Long Term Provisions 0.69 0.60 0.58 0.51 0.49 0.51 0.46 0.55 0.47 0.41 Current Liabilities 36.20 35.70 31.67 25.87 24.29 12.81 7.92 11.90 9.32 9.81 Trade Payables 9.91 9.54 6.62 3.54 7.45 5.60 5.58 7.14 5.51 5.65 Other Current Liabilities 5.94 4.94 8.60 10.87 9.16 7.13 2.28 3.56 3.63 4.13 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.01 0.00 1.14 0.10 0.00 Short Term Provisions 20.35 21.22 16.45 11.46 7.69 0.08 0.06 0.06 0.08 0.04 Total Liabilities 241.16 186.75 137.01 98.31 71.03 32.76 20.49 21.43 14.68 14.71 Net Block 38.02 32.66 19.43 18.95 17.08 14.61 10.59 10.63 9.37 9.71 Gross Block 51.21 44.04 28.24 25.52 21.93 18.10 12.86 11.75 41.61 40.76 Accumulated Depreciation 13.19 11.38 8.81 6.57 4.85 3.49 2.27 1.12 32.24 31.05 Non Current Assets 173.55 104.60 44.11 24.94 34.94 24.72 12.65 13.18 11.47 11.24 Capital Work in Progress 91.22 20.59 12.70 2.07 0.36 0.95 0.17 0.20 0.04 0.03 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 Long Term Loans & Adv. 9.92 9.81 2.77 2.61 2.38 2.45 1.62 2.08 1.74 1.29 Other Non Current Assets 34.39 41.53 9.21 1.31 15.12 6.71 0.27 0.27 0.32 0.20 Current Assets 67.60 82.15 92.90 73.37 36.08 8.04 7.84 8.25 3.21 3.48 Current Investments 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 Inventories 3.33 14.62 11.61 6.05 6.03 0.34 0.46 0.51 0.42 0.33 Sundry Debtors 27.03 17.91 25.12 14.71 20.23 5.80 2.72 6.99 2.16 2.37 Cash & Bank 8.16 9.33 12.35 27.64 2.08 1.70 4.46 0.41 0.19 0.23 Other Current Assets 29.09 1.37 1.76 1.98 7.74 0.20 0.20 0.35 0.44 0.54 Short Term Loans & Adv. 28.16 38.93 42.06 22.98 7.44 0.05 0.06 0.21 0.32 0.31 Net Current Assets 31.40 46.45 61.23 47.50 11.80 -4.77 -0.08 -3.65 -6.11 -6.33 Total Assets 241.15 186.75 137.01 98.31 71.02 32.76 20.49 21.43 14.68 14.72

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 64.21 39.48 40.31 10.53 0.63 0.69 5.59 2.80 3.91 2.71 PBT 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 4.59 Adjustment 0.46 -2.45 0.15 -0.24 0.65 -3.92 1.44 1.48 1.58 2.03 Changes in Working Capital 4.19 -15.11 -4.36 -19.98 -24.30 -2.45 -0.11 -2.94 -1.70 -3.69 Cash after chg. in Working capital 83.99 59.90 54.83 20.66 7.60 1.83 6.17 3.43 4.51 2.93 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.78 -20.42 -14.52 -10.13 -6.97 -1.14 -0.59 -0.63 -0.52 -0.19 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.07 -0.02 Cash From Investing Activity -55.21 -20.41 -29.83 -2.25 -2.98 -5.75 -1.03 -2.51 -0.78 -0.29 Net Fixed Assets -77.80 -23.69 -13.35 -5.30 -3.24 -6.02 -1.08 29.70 -0.86 1.93 Net Investments 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 Others 22.59 3.28 -16.48 3.04 0.26 0.27 0.05 -32.21 0.08 -2.22 Cash from Financing Activity -8.59 -13.27 -14.00 -5.16 2.10 5.29 -3.80 -0.19 -3.15 -3.13 Net Cash Inflow / Outflow 0.41 5.79 -3.51 3.12 -0.26 0.23 0.76 0.10 -0.01 -0.71 Opening Cash & Equivalents 6.05 0.26 3.97 0.86 1.12 0.89 0.13 0.03 0.04 0.75 Closing Cash & Equivalent 6.47 6.05 0.46 3.97 0.86 1.12 0.89 0.13 0.03 0.04

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 18.48 13.69 14.22 48.14 29.04 12.75 8.34 5.65 2.65 -0.54 ROA 27.65% 35.81% 37.08% 35.65% 45.62% 24.07% 18.45% 24.25% 31.50% 29.88% ROE 33.76% 45.92% 50.35% 53.82% 77.99% 41.85% 38.06% 72.63% 302.71% 0.00% ROCE 45.40% 61.51% 67.91% 67.89% 85.96% 44.88% 42.22% 54.67% 80.38% 113.74% Fixed Asset Turnover 3.57 4.11 4.27 3.82 4.25 2.65 3.15 1.34 0.79 0.75 Receivable days 48.29 52.91 63.29 70.42 55.80 37.88 45.67 46.80 25.38 20.96 Inventory Days 19.29 32.26 28.06 24.34 13.65 3.55 4.57 4.73 4.19 4.57 Payable days 99.37 114.42 115.10 132.50 42.12 60.55 72.03 77.99 76.35 77.95 Cash Conversion Cycle -31.80 -29.25 -23.75 -37.74 27.33 -19.12 -21.79 -26.47 -46.78 -52.42 Total Debt/Equity 0.00 0.00 0.00 0.04 0.19 0.32 0.05 0.49 0.86 -7.74 Interest Cover 347.14 440.64 72.31 42.66 34.85 52.71 12.59 12.96 13.26 12.86

Top Investors:

quant mutual fund - quant manufacturing fund

dipak kanayalal shah

Annual Reports:

News Update:

Gujarat Themis Biosyn starts commercial production in newly set up API plant in Gujarat
6th May 2025, 15:45 PM

The facility will support company’s forward integration initiatives and strengthen its position in export markets, particularly in the United States and Europe
Read More
Guj. Themis Biosyn - Quarterly Results
14th Feb 2025, 13:17 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback